OXURION (EBR:OXUR) | WebDisclosure

Basculer en Français

10603	Companies
225009	Keywords
153732	Articles
119071	Press releases

Home
Companies
OXURION

PRESS RELEASE

published on 01/13/2025 at 18:00, 1 year 5 months ago

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Atlas Special Opportunities, LLC converted 4 convertible bonds in Oxurion, leading to a EUR 100,000 capital increase. Oxurion focuses on developing vision-preserving therapeutics for the elderly

Capital Increase Oxurion Atlas Special Opportunities, LLC Innovative Therapeutics Elderly Vision
PRESS RELEASE

published on 01/13/2025 at 18:00, 1 year 5 months ago

Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie
Atlas Special Opportunities, LLC convertit 4 obligations convertibles en Oxurion pour une augmentation de capital de 100 000 EUR, soutenant le développement de médicaments pour préserver la vision des personnes âgées

Obligations Convertibles Augmentation De Capital Atlas Special Opportunities Médicaments Innovants Oxurion
BRIEF

published on 01/06/2025 at 18:05, 1 year 5 months ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Transparency Biopharmaceutical Shareholding Atlas Special Opportunities Oxurion
BRIEF

published on 01/06/2025 at 18:05, 1 year 5 months ago

Oxurion reçoit une notification de transparence de la part d'Atlas Special Opportunities LLC

Actionnariat Transparence Biopharmaceutique Oxurion Opportunités Spéciales Atlas
PRESS RELEASE

published on 01/06/2025 at 18:00, 1 year 5 months ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
Oxurion NV received a transparency notification from Atlas Special Opportunities, LLC revealing a stake above 15% threshold due to purchase of voting securities

Transparency Notification Biopharmaceutical Atlas Special Opportunities Ophthalmic Therapies Oxurion NV
PRESS RELEASE

published on 01/06/2025 at 18:00, 1 year 5 months ago

Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC
Oxurion NV receives transparency notification from Atlas Special Opportunities LLC regarding ownership of 624,817 shares, exceeding the 15% threshold

Transparency Notification Share Ownership Atlas Special Opportunities LLC Oxurion NV Ophthalmological Therapies
BRIEF

published on 01/03/2025 at 18:05, 1 year 5 months ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Shares Transparency Biopharmaceutical Atlas Special Opportunities Oxurion
BRIEF

published on 01/03/2025 at 18:05, 1 year 5 months ago

Oxurion reçoit une notification de transparence de la part d'Atlas Special Opportunities LLC

Actions Transparence Biopharmaceutique Oxurion Opportunités Spéciales Atlas
PRESS RELEASE

published on 01/03/2025 at 18:00, 1 year 5 months ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
Oxurion NV received a transparency notification under Belgian Transparency legislation from Atlas Special Opportunities, LLC, regarding the sale of voting securities

Transparency Notification Atlas Special Opportunities LLC Oxurion NV Belgian Legislation Retinal Disease Therapy
PRESS RELEASE

published on 01/03/2025 at 18:00, 1 year 5 months ago

Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC
Oxurion NV announces receipt of transparency notification regarding shareholding. Bio-pharmaceutical company developing ophthalmological therapies. Refer to website for more details

Transparency Notification Shareholding Belgium Oxurion NV Ophthalmological Therapies

Accesswire

Published on 06/20/2026 at 01:00, 8 hours 43 minutes ago

Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 9 hours 43 minutes ago

Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 1 day 5 hours ago

Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 1 day 8 hours ago

American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 1 day 8 hours ago

Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting

View all ACCESSWIRE

EQS Group

Published on 06/20/2026 at 06:00, 3 hours 43 minutes ago

Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 13 hours 25 minutes ago

2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 20:17, 13 hours 25 minutes ago

2CRSi SA: 2CRSi répond point par point au rapport de Grizzly Research et réaffirme la réalité de son activité
Published on 06/19/2026 at 19:01, 14 hours 41 minutes ago

Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting
Published on 06/19/2026 at 18:29, 15 hours 14 minutes ago

Designated Person Notification

Les Echos

Published on 06/19/2026 at 19:33, 14 hours 9 minutes ago

Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 14 hours 9 minutes ago

Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 14 hours 19 minutes ago

Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
Published on 06/19/2026 at 19:23, 14 hours 19 minutes ago

Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
Published on 06/19/2026 at 19:05, 14 hours 38 minutes ago

CP - Changement de gouvernance

View all LES ECHOS COMFI WIRE